RxDoctor Payments Data

John Alexis, MD

Clinical Pathology/Laboratory Medicine · Miami Beach, FLNPI 1215902143

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $193 and has fallen 92.0% since, to $15 in 2024. That places this record below the midpoint for clinical pathology/laboratory medicine clinicians in FL, where the typical reported total is $269.

$225in general payments, 2019–2025

Across 12 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Foundation Medicine, Inc.$49
  • AstraZeneca$42
  • Amgen$38
  • Roche Diagnostics Corporation$21
  • Rigel Pharmaceuticals, Inc.$18
  • Merck$16
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$225100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$225 in reported general payments places this provider in the 45th percentile of 43 clinical pathology/laboratory medicine providers in Florida.

See all clinical pathology/laboratory medicine providers in Florida

Medicare billing

Part B allowed, 2024
$41,870
Medicare patients
421
Services billed
1,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →